#USA #Rancho Mirage #Cutiva™ #Resivant #skin closure

Resivant Medical Marks a New Era in Skin Closure Technology

On August 18, 2026, Resivant Medical proudly announced a significant breakthrough in medical adhesives with the introduction of its Cutiva™ PLUS Skin Closure System. Following rigorous scientific research and development, this innovative product signifies the first clinical application of a unique silicone cyanoacrylate formulation in the realm of skin adhesives.

A Revolutionary Adhesive Formula

The Cutiva™ PLUS system integrates a newly developed adhesive chemistry that combines the robust bonding characteristics of super glue with the advantageous properties of crosslinked silicone rubber. The outcome is an enhanced skin adhesive that not only offers superior wound closure but also promotes durability, flexibility, and a heightened sense of safety and comfort for patients undergoing surgeries.

Performed on June 22 and June 23, 2026, the inaugural procedures were overseen by renowned orthopedic surgeon Dr. David Friscia at Eisenhower Health in Rancho Mirage, California. All surgeries proceeded smoothly and without complications, marking a triumphant beginning for the human applications of this cutting-edge technology.

Importance of the Milestone

Darren Obrigkeit, the CEO of Resivant Medical, emphasized the significance of this achievement. “Successfully utilizing Cutiva™ PLUS in patients reflects an essential milestone for our company,” he stated. “This accomplishment is the culmination of years dedicated to scientific exploration and operational development. We express our utmost gratitude to Dr. Friscia and the Eisenhower Health team for their collaboration, and we eagerly anticipate expanding clinical applications as we gear up for broader commercialization.”

In the operating room, Dr. Friscia noted the impressive performance of the Cutiva™ PLUS system. He highlighted that flexibility and durability are paramount in foot and ankle surgery due to constant mechanical stress at incision sites. “Cutiva™ PLUS performed as promised, and the mesh provided additional support that conventional topical adhesives lack,” he commented.

Features of Cutiva™ PLUS

The Cutiva™ PLUS Skin Closure System consists of a high-viscosity, non-run liquid adhesive paired with a surgical mesh patch, conveniently dispensed via a single-handed applicator for precision application. Unlike traditional topical adhesives, this innovative system minimizes the risk of adverse skin reactions, enhancing patient comfort.

Additionally, it creates a protective microbial barrier over the surgical incision, negating the requirement for extra dressings. With the added advantage of easy removal that doesn't damage surrounding skin, Cutiva™ PLUS is anticipated to be an asset across various surgical specialties. Its robust wound closure capability coupled with improved flexibility and comfort positions it as a versatile solution in modern surgical practices.

Future Prospects

Resivant Medical is actively onboarding additional clinical sites to facilitate the use of Cutiva™ PLUS, with expectations of gathering further clinical experiences and case results over the upcoming months. This promising technology originates from pioneering research in medical adhesives at the University of Akron and is secured by an expanding portfolio of intellectual property.

About Resivant Medical

Founded to pioneer advanced medical adhesive solutions, Resivant Medical is committed to enhancing patient outcomes and operational efficiency for healthcare professionals. Their extensive range of skin closure adhesive products is tailored for topical applications on various wounds and surgical sites, affirming their position at the forefront of wound care innovation.

For further insights and updates, please visit www.resivant.com.